Lifevantage Corporation (NASDAQ:LFVN) Short Interest Up 32.2% in January

Lifevantage Corporation (NASDAQ:LFVN) was the recipient of a significant increase in short interest during the month of January. As of January 30th, there was short interest totaling 3,664,089 shares, an increase of 32.2% from the January 15th total of 2,771,966 shares. Based on an average daily volume of 280,426 shares, the days-to-cover ratio is presently 13.1 days. Approximately 36.7% of the shares of the company are short sold. Approximately 36.7% of the shares of the company are short sold. Based on an average daily volume of 280,426 shares, the days-to-cover ratio is presently 13.1 days.

Insider Activity

In related news, Director Michael A. Beindorff sold 12,607 shares of Lifevantage stock in a transaction dated Wednesday, November 19th. The stock was sold at an average price of $6.42, for a total transaction of $80,936.94. Following the completion of the sale, the director owned 43,806 shares of the company’s stock, valued at $281,234.52. The trade was a 22.35% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 21.95% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. Cubist Systematic Strategies LLC purchased a new stake in Lifevantage in the 1st quarter worth $97,000. Jones Financial Companies Lllp grew its position in shares of Lifevantage by 14,484.0% in the first quarter. Jones Financial Companies Lllp now owns 29,168 shares of the company’s stock valued at $425,000 after purchasing an additional 28,968 shares during the period. Goldman Sachs Group Inc. grew its position in shares of Lifevantage by 24.5% in the first quarter. Goldman Sachs Group Inc. now owns 44,518 shares of the company’s stock valued at $649,000 after purchasing an additional 8,762 shares during the period. Jane Street Group LLC increased its stake in shares of Lifevantage by 5.4% during the first quarter. Jane Street Group LLC now owns 36,567 shares of the company’s stock worth $533,000 after purchasing an additional 1,877 shares in the last quarter. Finally, AlphaQuest LLC raised its position in shares of Lifevantage by 12,659.7% during the 2nd quarter. AlphaQuest LLC now owns 7,911 shares of the company’s stock worth $103,000 after purchasing an additional 7,849 shares during the last quarter. Hedge funds and other institutional investors own 35.32% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on LFVN shares. Loop Capital set a $5.00 price target on shares of Lifevantage in a research report on Thursday, February 5th. Wall Street Zen cut shares of Lifevantage from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Lake Street Capital restated a “buy” rating on shares of Lifevantage in a research report on Thursday, February 5th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Lifevantage in a research report on Monday, December 29th. One investment analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, Lifevantage currently has an average rating of “Moderate Buy” and an average price target of $5.00.

Lifevantage Price Performance

LFVN stock traded down $0.09 during midday trading on Tuesday, hitting $4.94. 205,428 shares of the stock traded hands, compared to its average volume of 269,959. Lifevantage has a 1-year low of $3.90 and a 1-year high of $19.28. The stock’s fifty day simple moving average is $5.94 and its 200-day simple moving average is $8.47. The firm has a market cap of $63.18 million, a P/E ratio of 8.23 and a beta of 0.33.

Lifevantage (NASDAQ:LFVN) last posted its earnings results on Wednesday, February 4th. The company reported $0.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by ($0.07). Lifevantage had a return on equity of 29.59% and a net margin of 3.74%.The firm had revenue of $48.93 million for the quarter, compared to analysts’ expectations of $54.40 million. Lifevantage has set its FY 2026 guidance at 0.600-0.800 EPS.

Lifevantage Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be given a $0.045 dividend. The ex-dividend date is Monday, March 2nd. This represents a $0.18 dividend on an annualized basis and a dividend yield of 3.6%. Lifevantage’s payout ratio is 30.00%.

Lifevantage Company Profile

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.